journal cover

The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo

Psychopharmacologia

Oct 14, 1975

J Gerlach, K Lühdorf

PMID: 706

Abstract

Thirteen out of 18 young out-patients with simple schizophrenia under neuroleptic treatment completed a double-blind cross-over trial with Madopar [L-Dopa + benserazid (a peripheral decarboxylase inhibitor)] and placebo. Nine patients were given 900 mg L-Dopa + 225 mg benserazid daily, ...read more

Mentioned in this Paper

Hydrazines
Mood (Psychological Function)
Nervousness
Brief Psychiatric Rating Scale
Anxiety Disorders
Placebos
Ro 4-4602
Schizophrenia
Schizophrenic Psychology
Antipsychotic Effect
5
1
Paper Details
References
  • References13
  • Citations32

The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo

Psychopharmacologia

Oct 14, 1975

J Gerlach, K Lühdorf

PMID: 706

DOI:

Abstract

Thirteen out of 18 young out-patients with simple schizophrenia under neuroleptic treatment completed a double-blind cross-over trial with Madopar [L-Dopa + benserazid (a peripheral decarboxylase inhibitor)] and placebo. Nine patients were given 900 mg L-Dopa + 225 mg benserazid daily, ...read more

Mentioned in this Paper

Hydrazines
Mood (Psychological Function)
Nervousness
Brief Psychiatric Rating Scale
Anxiety Disorders
Placebos
Ro 4-4602
Schizophrenia
Schizophrenic Psychology
Antipsychotic Effect
5
1
Paper Details
References
  • References13
  • Citations32
/papers/the-effect-of-l-dopa-on-young-patients-with/706